Gene · 4139
Papers1,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Aceclofenac/Citronellol Oil Nanoemulsion Repurposing Study: Formulation, In Vitro Characterization, and In Silico Evaluation of Their Antiproliferative and Pro-Apoptotic Activity against Melanoma Cell Line. | Biomedicines | 2023 | 37760972 | PubTator, text mining | PubMed |
| Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study. | Cancers (Basel) | 2023 | 37760593 | PubTator, text mining | PubMed |
| What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research. | PLOS Glob Public Health | 2023 | 37747872 | PubTator, text mining | PubMed |
| Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway. | Cancer Cell Int | 2023 | 37743467 | PubTator, text mining | PubMed |
| Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer's pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways. | Sci Rep | 2023 | 37735227 | PubTator, text mining | PubMed |
| Protocol for reconstitution of oligomeric assembly of NAIP5-NLRC4 inflammasome in vitro. | STAR Protoc | 2023 | 37733592 | PubTator, text mining | PubMed |
| Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis. | Acta Neuropathol Commun | 2023 | 37715247 | PubTator, text mining | PubMed |
| Interactions between microglia and glioma in tumor microenvironment. | Front Oncol | 2023 | 37700840 | PubTator, text mining | PubMed |
Combination of bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba. | BMC Complement Med Ther | 2023 | 37700261 | PubTator, text mining | PubMed |
| Network pharmacology- and molecular docking-based analyses of the antihypertensive mechanism of Ilex kudingcha. | Front Endocrinol (Lausanne) | 2023 | 37664830 | PubTator, text mining | PubMed |
| Nephroprotective Effects of Cardamonin on Renal Ischemia Reperfusion Injury/UUO-Induced Renal Fibrosis. | J Agric Food Chem | 2023 | 37646396 | PubTator, text mining | PubMed |
| Computational analysis of regulatory regions in human protein kinases. | Protein Sci | 2023 | 37632170 | PubTator, text mining | PubMed |
| Is Slovakia Almost a Hepatitis D Free Country? | Viruses | 2023 | 37632037 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents. | Int J Mol Sci | 2023 | 37628906 | PubTator, text mining | PubMed |
| Transcriptome Highlights Cannabinol Modulation of Mitophagy in a Parkinson's Disease In Vitro Model. | Biomolecules | 2023 | 37627228 | PubTator, text mining | PubMed |
| Helicobacter pylori and epithelial mesenchymal transition in human gastric cancers: An update of the literature. | Heliyon | 2023 | 37609398 | PubTator, text mining | PubMed |
| Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia. | World J Surg Oncol | 2023 | 37605192 | PubTator, text mining | PubMed |
| STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. | Mol Cancer | 2023 | 37573301 | PubTator, text mining | PubMed |
| Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease. | Int J Mol Sci | 2023 | 37569296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4139/papers?page=5